You have free access to this content

Alimentary Pharmacology & Therapeutics

Cover image for Vol. 36 Issue 11-12

December 2012

Volume 36, Issue 11-12

Pages 997–1109

  1. REVIEW ARTICLES

    1. Top of page
    2. REVIEW ARTICLES
    3. INFLAMMATORY BOWEL DISEASE
    4. NON-ALCOHOLIC FATTY LIVER DISEASE
    5. GASTRIC CARCINOIDS
    6. HELICOBACTER PYLORI
    7. IRRITABLE BOWEL SYNDROME
    8. INVITED COMMENTARIES
    9. LETTERS TO THE EDITORS
    10. CORRIGENDA
    1. You have free access to this content
    2. You have free access to this content
      Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome (pages 1009–1031)

      J. Matricon, M. Meleine, A. Gelot, T. Piche, M. Dapoigny, E. Muller and D. Ardid

      Version of Record online: 15 OCT 2012 | DOI: 10.1111/apt.12080

  2. INFLAMMATORY BOWEL DISEASE

    1. Top of page
    2. REVIEW ARTICLES
    3. INFLAMMATORY BOWEL DISEASE
    4. NON-ALCOHOLIC FATTY LIVER DISEASE
    5. GASTRIC CARCINOIDS
    6. HELICOBACTER PYLORI
    7. IRRITABLE BOWEL SYNDROME
    8. INVITED COMMENTARIES
    9. LETTERS TO THE EDITORS
    10. CORRIGENDA
    1. You have free access to this content
      Impact of Clostridium difficile colitis on 5-year health outcomes in patients with ulcerative colitis (pages 1032–1039)

      S. K. Murthy, A. H. Steinhart, J. Tinmouth, P. C. Austin, N. Daneman and G. C. Nguyen

      Version of Record online: 14 OCT 2012 | DOI: 10.1111/apt.12073

    2. You have free access to this content
      Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab? (pages 1040–1048)

      C. Reenaers, E. Louis, J. Belaiche, L. Seidel, S. Keshav and S. Travis

      Version of Record online: 14 OCT 2012 | DOI: 10.1111/apt.12076

    3. You have free access to this content
  3. NON-ALCOHOLIC FATTY LIVER DISEASE

    1. Top of page
    2. REVIEW ARTICLES
    3. INFLAMMATORY BOWEL DISEASE
    4. NON-ALCOHOLIC FATTY LIVER DISEASE
    5. GASTRIC CARCINOIDS
    6. HELICOBACTER PYLORI
    7. IRRITABLE BOWEL SYNDROME
    8. INVITED COMMENTARIES
    9. LETTERS TO THE EDITORS
    10. CORRIGENDA
    1. You have free access to this content
      Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers (pages 1057–1066)

      J. Shen, H. L.-Y. Chan, G. L.-H. Wong, A. W.-H. Chan, P. C.-L. Choi, H.-Y. Chan, A. M.-L. Chim, D. K.-W. Yeung, J. Yu, W. C.-W. Chu and V. W.-S. Wong

      Version of Record online: 16 OCT 2012 | DOI: 10.1111/apt.12091

  4. GASTRIC CARCINOIDS

    1. Top of page
    2. REVIEW ARTICLES
    3. INFLAMMATORY BOWEL DISEASE
    4. NON-ALCOHOLIC FATTY LIVER DISEASE
    5. GASTRIC CARCINOIDS
    6. HELICOBACTER PYLORI
    7. IRRITABLE BOWEL SYNDROME
    8. INVITED COMMENTARIES
    9. LETTERS TO THE EDITORS
    10. CORRIGENDA
    1. You have free access to this content
  5. HELICOBACTER PYLORI

    1. Top of page
    2. REVIEW ARTICLES
    3. INFLAMMATORY BOWEL DISEASE
    4. NON-ALCOHOLIC FATTY LIVER DISEASE
    5. GASTRIC CARCINOIDS
    6. HELICOBACTER PYLORI
    7. IRRITABLE BOWEL SYNDROME
    8. INVITED COMMENTARIES
    9. LETTERS TO THE EDITORS
    10. CORRIGENDA
    1. You have free access to this content
      Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations (pages 1076–1083)

      C. Y. Tay, H. M. Windsor, F. Thirriot, W. Lu, C. Conway, T. T. Perkins and B. J. Marshall

      Version of Record online: 16 OCT 2012 | DOI: 10.1111/apt.12089

  6. IRRITABLE BOWEL SYNDROME

    1. Top of page
    2. REVIEW ARTICLES
    3. INFLAMMATORY BOWEL DISEASE
    4. NON-ALCOHOLIC FATTY LIVER DISEASE
    5. GASTRIC CARCINOIDS
    6. HELICOBACTER PYLORI
    7. IRRITABLE BOWEL SYNDROME
    8. INVITED COMMENTARIES
    9. LETTERS TO THE EDITORS
    10. CORRIGENDA
    1. You have free access to this content
  7. INVITED COMMENTARIES

    1. Top of page
    2. REVIEW ARTICLES
    3. INFLAMMATORY BOWEL DISEASE
    4. NON-ALCOHOLIC FATTY LIVER DISEASE
    5. GASTRIC CARCINOIDS
    6. HELICOBACTER PYLORI
    7. IRRITABLE BOWEL SYNDROME
    8. INVITED COMMENTARIES
    9. LETTERS TO THE EDITORS
    10. CORRIGENDA
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
    6. You have free access to this content
    7. You have free access to this content
      Commentary: psychological disorders linked to functional dyspepsia (pages 1099–1100)

      N. A. Koloski, M. Jones and N. J. Talley

      Version of Record online: 7 NOV 2012 | DOI: 10.1111/apt.12079

    8. You have free access to this content
      Commentary: psychological disorders linked to functional dyspepsia – authors' reply (pages 1100–1101)

      A. D. P. Mak, J. C. Y. Wu, Y. Chan, F. K. L. Chan, J. J. Y. Sung and S. Lee

      Version of Record online: 7 NOV 2012 | DOI: 10.1111/apt.12082

    9. You have free access to this content
  8. LETTERS TO THE EDITORS

    1. Top of page
    2. REVIEW ARTICLES
    3. INFLAMMATORY BOWEL DISEASE
    4. NON-ALCOHOLIC FATTY LIVER DISEASE
    5. GASTRIC CARCINOIDS
    6. HELICOBACTER PYLORI
    7. IRRITABLE BOWEL SYNDROME
    8. INVITED COMMENTARIES
    9. LETTERS TO THE EDITORS
    10. CORRIGENDA
    1. You have free access to this content
      Letter: surveillance of Helicobacter pylori antibiotic resistance (page 1102)

      B. Porowska, M. T. Mascellino and C. Severi

      Version of Record online: 7 NOV 2012 | DOI: 10.1111/apt.12070

    2. You have free access to this content
      Letter: surveillance of Helicobacter pylori antibiotic resistance – authors' reply (page 1103)

      C. A. M. McNulty, G. Lasseter, I. Shaw, T. Nichols, S. D'Arcy, A. J. Lawson and E. Glocker

      Version of Record online: 7 NOV 2012 | DOI: 10.1111/apt.12093

    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
    6. You have free access to this content
      Letter: potential chemopreventive effects of statins in oesophageal adenocarcinoma – authors' reply (pages 1105–1106)

      L. Alexandre, A. B. Clark, E. Cheong, M. P. N. Lewis and A. R. Hart

      Version of Record online: 7 NOV 2012 | DOI: 10.1111/apt.12099

    7. You have free access to this content
    8. You have free access to this content
  9. CORRIGENDA

    1. Top of page
    2. REVIEW ARTICLES
    3. INFLAMMATORY BOWEL DISEASE
    4. NON-ALCOHOLIC FATTY LIVER DISEASE
    5. GASTRIC CARCINOIDS
    6. HELICOBACTER PYLORI
    7. IRRITABLE BOWEL SYNDROME
    8. INVITED COMMENTARIES
    9. LETTERS TO THE EDITORS
    10. CORRIGENDA
    1. You have free access to this content
      Corrigenda (page 1109)

      Version of Record online: 7 NOV 2012 | DOI: 10.1111/apt.12104

      This article corrects:

      Evaluation of a novel continuous real time 13C urea breath analyser for Helicobacter pylori

      Vol. 15, Issue 3, 389–394, Version of Record online: 7 JUL 2008

    2. You have free access to this content
      Corrigenda (page 1109)

      Version of Record online: 7 NOV 2012 | DOI: 10.1111/apt.12116

      This article corrects:

      Systematic review: hypomagnesaemia induced by proton pump inhibition

      Vol. 36, Issue 5, 405–413, Version of Record online: 4 JUL 2012

SEARCH

SEARCH BY CITATION